Paula Pons, MD
Undersea and Hyperbaric Medicine · Fayetteville, NYNPI 1679533483
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 98.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $71,604 and has fallen 99.5% since, to $384 in 2024.
Across 274 payments — averaging $648.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$175K
- Kerecis Limited$2K
- Angiodynamics, Inc.$440
- Smith+Nephew$143
- Integra Lifesciences Corporation$123
- AbbVie$116
- plus $264 from 8 others
What the payments were for
- Consulting fees$63,12536%
- Speaking & faculty fees$93,08052%
- Travel & lodging$15,9819%
- Food & beverage$5,5013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 237 | $174,958 |
| Kerecis Limited | 2 | $1,643 |
| Angiodynamics, Inc. | 2 | $440 |
| Smith+Nephew | 10 | $143 |
| Integra Lifesciences Corporation | 6 | $123 |
| AbbVie(2 entities) | 6 | $116 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $56 |
| Osiris Therapeutics Inc. | 1 | $48 |
| Intuitive Surgical | 1 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Hydrofera LLC | 1 | $27 |
| Molnlycke Health Care US, LLC | 1 | $23 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puraply Antimicrobial$72,241
- PuraPly$57,416
- Apligraf$38,439
- Dermagraft$31,066
- Puraply/Affinity/NuTech$31,066
- Kerecis Omega3 SurgiClose$4,643
- Affinity$2,900
- Kerecis Omega3 Marigen$1,928
- Kerecis Omega3 GraftGuide$1,643
- NuShield$175
How this compares
Too few undersea and hyperbaric medicine providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 13 | $211 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $202 |
| Triamcinolone Acetonide | 16 | $58 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Fayetteville
- Glenn SloatAlbany$6K
- Diego EscobarNew Rochelle$3K
- Kurt DischnerRockville Centre$2K
- James PfeiffRome$851
- Kausik KarValhalla$764
- Nicholas VaccariBrooklyn$569
- Peter SalzerPlainview$220
- Joan ChouSyracuse$147
- Peter MarianiSyracuse$53
- Aaron ZellSaratoga Springs$22
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.